Table 1.
Clinical feature | % (n/N) |
---|---|
Patients | 1,603 |
Main characteristics | |
Age at disease onset (years, means ± SE) | 54.1 ± 14.8 |
Follow up (years, means ± SE) | 11 ± 7.5 |
Female | 73.5 |
Rheumatoid factor positive | 70.3 (996/1,417) |
Shared Epitope positive | 63.7 (592/930) |
Anti-CCP antibodies positive | 58.1 (652/1,123) |
Cardiovascular risk factors | |
Hypertension | 39.4 (516/1,310) |
Diabetes mellitus | 13.2 (171/1,300) |
Dyslipidemia | 41.3 (540/1,307) |
Obesity | 12.4 (142/1,146) |
Smoking habit | 24.0 (303/1,261) |
Patients with cardiovascular events | 17.8 (229/1,284) |
Ischemic heart disease | 9.5 (122/1,284) |
Heart failure | 4.8 (62/1,284) |
Cerebrovascular accidents | 4.6 (59/1,284) |
Peripheral arteriopathy | 1.9 (25/1,284) |
SE, Standard error
Anti-CCP antibodies, anti-cyclic citrullinated peptide antibodies